Fetal Lead Exposure at Each Stage of Pregnancy as a Predictor of Infant Mental Development

DSpace/Manakin Repository

Fetal Lead Exposure at Each Stage of Pregnancy as a Predictor of Infant Mental Development

Citable link to this page

. . . . . .

Title: Fetal Lead Exposure at Each Stage of Pregnancy as a Predictor of Infant Mental Development
Author: Hu, Howard; Téllez-Rojo, Martha María; Lamadrid-Figueroa, Héctor; Schnaas, Lourdes; Mercado-García, Adriana; Hernández-Avila, Mauricio; Bellinger, David C.; Smith, Donald; Ettinger, Adrienne S; Schwartz, Joel David

Note: Order does not necessarily reflect citation order of authors.

Citation: Hu, Howard, Martha Mari­a Tellez-Rojo, David Bellinger, Donald Smith, Adrienne S. Ettinger, Hector Lamadrid-Figueroa, Joel Schwartz, Lourdes Schnaas, Adriana Mercado-Garci­a, and Mauricio Hernandez-Avila. 2006. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environmental Health Perspectives 114(11): 1730-1735.
Full Text & Related Files:
Abstract: Background: The impact of prenatal lead exposure on neurodevelopment remains unclear in terms of consistency, the trimester of greatest vulnerability, and the best method for estimating fetal lead exposure. Objective: We studied prenatal lead exposure’s impact on neurodevelopment using repeated measures of fetal dose as reflected by maternal whole blood and plasma lead levels. Methods: We measured lead in maternal plasma and whole blood during each trimester in 146 pregnant women in Mexico City. We then measured umbilical cord blood lead at delivery and, when offspring were 12 and 24 months of age, measured blood lead and administered the Bayley Scales of Infant Development. We used multivariate regression, adjusting for covariates and 24-month blood lead, to compare the impacts of our pregnancy measures of fetal lead dose. Results: Maternal lead levels were moderately high with a first-trimester blood lead mean (± SD) value of 7.1 ± 5.1 μg/dL and 14% of values ≥10 μg/dL. Both maternal plasma and whole blood lead during the first trimester (but not in the second or third trimester) were significant predictors (p less than 0.05) of poorer Mental Development Index (MDI) scores. In models combining all three trimester measures and using standardized coefficients, the effect of first-trimester maternal plasma lead was somewhat greater than the effect of first-trimester maternal whole blood lead and substantially greater than the effects of second- or third-trimester plasma lead, and values averaged over all three trimesters. A 1-SD change in first-trimester plasma lead was associated with a reduction in MDI score of 3.5 points. Postnatal blood lead levels in the offspring were less strongly correlated with MDI scores. Conclusions: Fetal lead exposure has an adverse effect on neurodevelopment, with an effect that may be most pronounced during the first trimester and best captured by measuring lead in either maternal plasma or whole blood.
Published Version: doi:10.1289/ehp.9067
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665421/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8157299

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters